Feed Explorer
Rate Of Return$Novo Nordisk AS(NVO.US) weight loss drug, a well-known pharmaceutical company with solid fundamentals. Novo Nordisk's semaglutide has been used for insulin and weight loss. It belongs to the insulin series and was one of the earliest products introduced by hospitals.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments